Table 2.
Classification of drug RCTs according to sponsor type
| Non-industry trial | Industry-supported trial | Industry-sponsored trial | ||
|---|---|---|---|---|
| 1. |
Pharmaceutical company explicitly reported as study sponsor in manuscript |
|
|
X |
| 2. |
Company funding the trial participated in design, conduct, analysis, writing of article and/or decision to publish |
|
|
X |
| 3. |
Trial funded by industry and author(s) affiliated to industry, but role of funding source not reported |
|
|
X |
| 4. |
Financial support received from pharmaceutical company |
|
X |
|
| 5. |
Donation of study medication or placebos by manufacturer |
|
X |
|
| 6. |
One or more authors employed by pharmaceutical company manufacturing the test drug |
|
X |
|
| 7. |
Trial supported by nonprofit organisation owned by pharmaceutical company |
|
X |
|
| 8. |
Investigator-initiated post-hoc analysis of single RCT formally sponsored by industry |
|
X |
|
| 9. |
Pharmaceutical industry not in any way involved in trial |
X |
|
|
| Formal study sponsor according to ICH-GCP guidelines |
Nonprofit organisation |
Nonprofit organisation |
Pharmaceutical company |
|
| Responsible party for quality and safety measures during trial | Nonprofit organisation | Nonprofit organisation | Pharmaceutical company | |